secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K/A
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001299130-24-000165
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 2.05
LLM model:  deepseek-v4-flash:cloud@v2

Pacific Biosciences estimates $27M in charges for expense reduction plan; San Diego office closure
--------------------------------------------------------------------------------

- Total charges estimated at $27M in fiscal 2024, including $10M compensation, $12M lease costs, $4M inventory.
- Cash expenses of ~$21M: $10M severance and benefits, $11M San Diego office closure and lease costs.
- Substantially all charges expected in Q2 and Q3 2024; company had previously disclosed plan on April 16, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000165/0001299130-24-000165-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000165/pacb-20240416.htm
  HTML page:      https://secwatch.observer/filing/0001299130-24-000165

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer